140 related articles for article (PubMed ID: 22575418)
1. Aspirin response variability after major orthopedic surgery.
Li C; Hirsh J; Sloane D; Liang Y; Bai J; Paikin J; Johnston MA; DeBeer J; Eikelboom JW
Thromb Res; 2012 Aug; 130(2):216-20. PubMed ID: 22575418
[TBL] [Abstract][Full Text] [Related]
2. Individual variability of response and non-response to acetyl salicylic acid after cardiac surgery.
Börgermann J; Kanashnik A; Sossdorf M; Gummert J; Lösche W
Platelets; 2010; 21(8):610-5. PubMed ID: 20807171
[TBL] [Abstract][Full Text] [Related]
3. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
4. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients.
Zisman E; Erport A; Kohanovsky E; Ballagulah M; Cassel A; Quitt M; Pizov R
Eur J Anaesthesiol; 2010 Jul; 27(7):617-23. PubMed ID: 20035230
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of aspirin's effect on platelet function early after coronary artery bypass grafting.
Bednar F; Tencer T; Plasil P; Paluch Z; Sadilkova L; Prucha M; Kopa M
J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):575-80. PubMed ID: 22281116
[TBL] [Abstract][Full Text] [Related]
7. Dose- and time-dependent antiplatelet effects of aspirin.
Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
[TBL] [Abstract][Full Text] [Related]
8. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2).
Blais N; Pharand C; Lordkipanidzé M; Sia YK; Merhi Y; Diodati JG
Thromb Haemost; 2009 Aug; 102(2):404-11. PubMed ID: 19652893
[TBL] [Abstract][Full Text] [Related]
9. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
[TBL] [Abstract][Full Text] [Related]
10. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
[TBL] [Abstract][Full Text] [Related]
11. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
12. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
[TBL] [Abstract][Full Text] [Related]
13. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
14. Anti-platelet effect of aspirin is substantially reduced after administration of heparin during carotid endarterectomy.
Webster SE; Payne DA; Jones CI; Hayes PD; Bell PR; Goodall AH; Naylor AR
J Vasc Surg; 2004 Sep; 40(3):463-8. PubMed ID: 15337874
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
[TBL] [Abstract][Full Text] [Related]
16. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
18. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
19. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
20. A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane.
Carroll RC; Craft RM; Snider CC; Aligeti VR; Wortham DC
Anesth Analg; 2013 Feb; 116(2):282-6. PubMed ID: 23302970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
